BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33894142)

  • 1. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
    Dannenmann B; Klimiankou M; Oswald B; Solovyeva A; Mardan J; Nasri M; Ritter M; Zahabi A; Arreba-Tutusaus P; Mir P; Stein F; Kandabarau S; Lachmann N; Moritz T; Morishima T; Konantz M; Lengerke C; Ripperger T; Steinemann D; Erlacher M; Niemeyer CM; Zeidler C; Welte K; Skokowa J
    Cell Stem Cell; 2021 May; 28(5):906-922.e6. PubMed ID: 33894142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs.
    Ritter M; Klimiankou M; Klimenkova O; Schambach A; Hoffmann D; Schmidt A; Kanz L; Link DC; Welte K; Skokowa J
    Ann Hematol; 2020 Oct; 99(10):2329-2338. PubMed ID: 32821971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant Transformation Involving
    Olofsen PA; Fatrai S; van Strien PMH; Obenauer JC; de Looper HWJ; Hoogenboezem RM; Erpelinck-Verschueren CAJ; Vermeulen MPWM; Roovers O; Haferlach T; Jansen JH; Ghazvini M; Bindels EMJ; Schneider RK; de Pater EM; Touw IP
    Cell Rep Med; 2020 Aug; 1(5):100074. PubMed ID: 33205068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
    Skokowa J; Steinemann D; Katsman-Kuipers JE; Zeidler C; Klimenkova O; Klimiankou M; Unalan M; Kandabarau S; Makaryan V; Beekman R; Behrens K; Stocking C; Obenauer J; Schnittger S; Kohlmann A; Valkhof MG; Hoogenboezem R; Göhring G; Reinhardt D; Schlegelberger B; Stanulla M; Vandenberghe P; Donadieu J; Zwaan CM; Touw IP; van den Heuvel-Eibrink MM; Dale DC; Welte K
    Blood; 2014 Apr; 123(14):2229-37. PubMed ID: 24523240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-Sensitive
    Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
    Front Immunol; 2019; 10():116. PubMed ID: 30891028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation, expansion, and drug treatment of hematopoietic progenitor cells derived from human iPSCs.
    Dannenmann B; Skokowa J
    STAR Protoc; 2022 Jun; 3(2):101400. PubMed ID: 35600931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
    Beekman R; Valkhof MG; Sanders MA; van Strien PM; Haanstra JR; Broeders L; Geertsma-Kleinekoort WM; Veerman AJ; Valk PJ; Verhaak RG; Löwenberg B; Touw IP
    Blood; 2012 May; 119(22):5071-7. PubMed ID: 22371884
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Olofsen PA; Touw IP
    Mol Cells; 2020 Feb; 43(2):139-144. PubMed ID: 32041395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
    Qiu Y; Zhang Y; Hu N; Dong F
    J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
    Link DC; Kunter G; Kasai Y; Zhao Y; Miner T; McLellan MD; Ries RE; Kapur D; Nagarajan R; Dale DC; Bolyard AA; Boxer LA; Welte K; Zeidler C; Donadieu J; Bellanné-Chantelot C; Vardiman JW; Caligiuri MA; Bloomfield CD; DiPersio JF; Tomasson MH; Graubert TA; Westervelt P; Watson M; Shannon W; Baty J; Mardis ER; Wilson RK; Ley TJ
    Blood; 2007 Sep; 110(5):1648-55. PubMed ID: 17494858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes.
    Schmied L; Olofsen PA; Lundberg P; Tzankov A; Kleber M; Halter J; Uhr M; Valk PJM; Touw IP; Passweg J; Drexler B
    Blood Adv; 2020 Nov; 4(21):5540-5546. PubMed ID: 33166403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia.
    Klimiankou M; Mellor-Heineke S; Zeidler C; Welte K; Skokowa J
    Ann N Y Acad Sci; 2016 Apr; 1370(1):119-25. PubMed ID: 27270496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the unfolded protein response and oxidative stress on mutagenesis in CSF3R: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.
    Sapra A; Jaksik R; Mehta H; Biesiadny S; Kimmel M; Corey SJ
    Mutagenesis; 2020 Dec; 35(5):381-389. PubMed ID: 33511998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAALC gene expression tells a serious patient outcome tale in NPM1-wild type/FLT3-ITD negative cytogenetically normal-acute myeloid leukemia in adults.
    Verma D; Kumar R; Ali MS; Singh J; Arora M; Singh I; Kumari S; Bakhshi S; Sharma A; Palanichamy JK; Tanwar P; Singh AR; Chopra A
    Blood Cells Mol Dis; 2022 Jul; 95():102662. PubMed ID: 35429905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Game of clones: the genomic evolution of severe congenital neutropenia.
    Touw IP
    Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.
    Zhou JD; Yang L; Zhang YY; Yang J; Wen XM; Guo H; Yao DM; Ma JC; Chen Q; Lin J; Qian J
    Med Oncol; 2015 Jan; 32(1):386. PubMed ID: 25428390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel
    Connelly JA; Mody RJ; Wu YM; Robinson DR; Lonigro RJ; Vats P; Rabban E; Anderson B; Walkovich K
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29572239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations and clonal hematopoiesis in congenital neutropenia.
    Xia J; Miller CA; Baty J; Ramesh A; Jotte MRM; Fulton RS; Vogel TP; Cooper MA; Walkovich KJ; Makaryan V; Bolyard AA; Dinauer MC; Wilson DB; Vlachos A; Myers KC; Rothbaum RJ; Bertuch AA; Dale DC; Shimamura A; Boxer LA; Link DC
    Blood; 2018 Jan; 131(4):408-416. PubMed ID: 29092827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of leukemic transformation in congenital neutropenia.
    Link DC
    Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene Mutation and Acute Leukemia Transformation of Severe Congenital Neutropenia- Review].
    Chi ZH; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1580-1584. PubMed ID: 29070147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.